INOVIO PHARMACEUTICALS, INC. Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount
INOVIO PHARMACEUTICALS, INC. (INO) reported Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount of 54.78 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount · last filed 2026-08-12
- INOVIO PHARMACEUTICALS, INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2026-06-30 was 54.78M shares, a 325.53% increase year-over-year.
- INOVIO PHARMACEUTICALS, INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2026-03-31 was 28.68M shares, a 130.32% increase year-over-year.
- INOVIO PHARMACEUTICALS, INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-09-30 was 40.96M shares, a 2267.97% increase year-over-year.
- INOVIO PHARMACEUTICALS, INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-06-30 was 12.87M shares, a 621.85% increase year-over-year.
- INOVIO PHARMACEUTICALS, INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2025 was 40.68M shares, a 244.62% increase from fiscal 2024.
- INOVIO PHARMACEUTICALS, INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2024 was 11.80M shares, a 611.91% increase from fiscal 2023.
- INOVIO PHARMACEUTICALS, INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2023 was 1.66M shares, a 10.92% increase from fiscal 2022.
- INOVIO PHARMACEUTICALS, INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2022 was 1.49M shares, a 7.71% increase from fiscal 2021.
| Period end | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | 54.78M shares 10-Q · filed 2026-08-12 | 54.78M shares 10-Q · filed 2026-08-12 | ||||||
| 2026-03-31 | 28.68M shares 10-Q · filed 2026-05-13 | |||||||
| 2025-12-31 | 40.68M shares 10-K · filed 2026-03-12 | |||||||
| 2025-09-30 | 40.96M shares 10-Q · filed 2025-11-10 | 40.96M shares 10-Q · filed 2025-11-10 | ||||||
| 2025-06-30 | 12.87M shares 10-Q · filed 2026-08-12 | 12.87M shares 10-Q · filed 2026-08-12 | ||||||
| 2025-03-31 | 12.45M shares 10-Q · filed 2026-05-13 | |||||||
| 2024-12-31 | 11.80M shares 10-K · filed 2026-03-12 | |||||||
| 2024-09-30 | 1.73M shares 10-Q · filed 2025-11-10 | 1.73M shares 10-Q · filed 2025-11-10 | ||||||
| 2024-06-30 | 1.78M shares 10-Q · filed 2025-08-12 | 1.78M shares 10-Q · filed 2025-08-12 | ||||||
| 2024-03-31 | 1.75M shares 10-Q · filed 2025-05-13 | |||||||
| 2023-12-31 | 1.66M shares 10-K · filed 2025-03-18 | |||||||
| 2023-09-30 | 1.74M shares 10-Q · filed 2024-11-14 | 20.90M shares 10-Q · filed 2023-11-09 | 1.74M shares 10-Q · filed 2024-11-14 | 20.90M shares 10-Q · filed 2023-11-09 | ||||
| 2023-06-30 | 1.82M shares 10-Q · filed 2024-08-08 | 21.89M shares 10-Q · filed 2023-08-09 | 1.82M shares 10-Q · filed 2024-08-08 | 21.89M shares 10-Q · filed 2023-08-09 | ||||
| 2023-03-31 | 1.71M shares 10-Q · filed 2024-05-13 | 20.46M shares 10-Q · filed 2023-05-10 | ||||||
| 2022-12-31 | 1.49M shares 10-K · filed 2024-03-06 | 17.94M shares 10-K · filed 2023-03-01 | ||||||
| 2022-09-30 | 19.19M shares 10-Q · filed 2023-11-09 | 19.19M shares 10-Q · filed 2023-11-09 | ||||||
| 2022-06-30 | 20.33M shares 10-Q · filed 2023-08-09 | 20.33M shares 10-Q · filed 2023-08-09 | ||||||
| 2022-03-31 | 21.31M shares 10-Q · filed 2023-05-10 | |||||||
| 2021-12-31 | 1.39M shares 10-K · filed 2024-03-06 | 16.65M shares 10-K · filed 2022-03-01 | ||||||
| 2021-09-30 | 16.62M shares 10-Q · filed 2022-11-08 | 16.62M shares 10-Q · filed 2022-11-08 | ||||||
| 2021-06-30 | 16.56M shares 10-Q · filed 2022-08-09 | 16.56M shares 10-Q · filed 2022-08-09 | ||||||
| 2021-03-31 | 17.15M shares 10-Q · filed 2022-05-10 | |||||||
| 2020-12-31 | 16.19M shares 10-K · filed 2023-03-01 | |||||||
| 2020-09-30 | 12.17M shares 10-Q · filed 2021-11-09 | 24.59M shares 10-Q · filed 2021-11-09 | ||||||
| 2020-06-30 | 32.62M shares 10-Q · filed 2020-08-10 | 32.62M shares 10-Q · filed 2021-08-09 | ||||||
| 2020-03-31 | 32.82M shares 10-Q · filed 2021-05-10 | |||||||
| 2019-12-31 | 30.74M shares 10-K · filed 2022-03-01 | |||||||
| 2019-09-30 | 26.69M shares 10-Q · filed 2020-11-09 | 30.49M shares 10-Q · filed 2020-11-09 | ||||||
| 2019-06-30 | 26.94M shares 10-Q · filed 2020-08-10 | 26.94M shares 10-Q · filed 2020-08-10 | ||||||
| 2019-03-31 | 27.34M shares 10-Q · filed 2020-05-11 | |||||||
| 2018-12-31 | 10.45M shares 10-K · filed 2021-03-01 | |||||||
| 2018-09-30 | 10.66M shares 10-Q · filed 2019-11-12 | 10.66M shares 10-Q · filed 2019-11-12 | ||||||
| 2018-06-30 | 11.02M shares 10-Q · filed 2019-08-08 | 11.02M shares 10-Q · filed 2019-08-08 | ||||||
| 2018-03-31 | 11.55M shares 10-Q · filed 2019-05-09 | |||||||
| 2017-12-31 | 8.94M shares 10-K · filed 2020-03-12 | |||||||
| 2017-09-30 | 9.14M shares 10-Q · filed 2018-11-08 | 9.14M shares 10-Q · filed 2018-11-08 | ||||||
| 2017-06-30 | 9.52M shares 10-Q · filed 2018-08-07 | 9.52M shares 10-Q · filed 2018-08-07 | ||||||
| 2017-03-31 | 9.23M shares 10-Q · filed 2018-05-09 | |||||||
| 2016-12-31 | 7.90M shares 10-K · filed 2019-03-12 | |||||||
| 2016-09-30 | 7.53M shares 10-Q · filed 2017-11-08 | 7.81M shares 10-Q · filed 2017-11-08 | ||||||
| 2016-06-30 | 7.74M shares 10-Q · filed 2017-08-08 | 7.74M shares 10-Q · filed 2017-08-08 | ||||||
| 2016-03-31 | 8.44M shares 10-Q · filed 2017-05-10 | |||||||
| 2015-12-31 | 6.38M shares 10-K · filed 2018-03-14 | |||||||
| 2015-09-30 | 2.82M shares 10-Q · filed 2016-11-09 | 6.69M shares 10-Q · filed 2016-11-09 | ||||||
| 2015-06-30 | 6.85M shares 10-Q · filed 2016-08-08 | 6.85M shares 10-Q · filed 2015-08-10 | ||||||
| 2015-03-31 | 6.80M shares 10-Q · filed 2016-05-09 | |||||||
| 2014-12-31 | 5.58M shares 10-K · filed 2017-03-15 | |||||||
| 2014-09-30 | 5.82M shares 10-Q · filed 2015-11-09 | 5.82M shares 10-Q · filed 2015-11-09 | ||||||
| 2014-06-30 | 6.04M shares 10-Q · filed 2014-08-11 | 6.04M shares 10-Q · filed 2015-08-10 | ||||||
| 2014-03-31 | 6.36M shares 10-Q · filed 2015-05-11 | 25.44M shares 10-Q · filed 2014-05-12 | ||||||
| 2013-12-31 | 7.66M shares 10-K · filed 2016-03-14 | 30.64M shares 10-K · filed 2014-03-17 | ||||||
| 2013-09-30 | 7.91M shares 10-Q · filed 2014-11-10 | 31.66M shares 10-Q · filed 2013-11-12 | ||||||
| 2013-06-30 | 13.42M shares 10-Q · filed 2014-08-11 | 53.66M shares 10-Q · filed 2013-08-09 | ||||||
| 2013-03-31 | 53.76M shares 10-Q · filed 2014-05-12 | |||||||
| 2012-12-31 | 9.47M shares 10-K · filed 2015-03-16 | 37.89M shares 10-K · filed 2013-03-18 | ||||||
| 2012-09-30 | 38.17M shares 10-Q · filed 2013-11-12 | |||||||
| 2012-06-30 | 38.21M shares 10-Q · filed 2013-08-09 | 38.21M shares 10-Q · filed 2012-08-09 | ||||||
| 2012-03-31 | 38.28M shares 10-Q · filed 2013-05-10 | |||||||
| 2011-12-31 | 36.08M shares 10-K · filed 2014-03-17 | |||||||
| 2011-09-30 | 32.79M shares 10-Q · filed 2012-11-07 | |||||||
| 2011-06-30 | 32.74M shares 10-Q · filed 2012-08-09 | |||||||
| 2010-12-31 | 20.46M shares 10-K · filed 2013-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |